Related Experiment Video
Updated: Mar 8, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Pediatric papillary thyroid cancer: current management challenges
Frederik A Verburg1, Hanneke M Van Santen2, Markus Luster1
1University Hospital Gießen and Marburg, Department of Nuclear Medicine, Marburg, Germany.
Insights
Pediatric differentiated thyroid cancer (DTC) is rare but increasing. This review covers diagnosis, surgery, and therapies for pediatric papillary thyroid cancer (PTC), highlighting management controversies and challenges.
Area of Science:
- Pediatric Oncology
- Endocrinology
Background:
- Differentiated thyroid cancer (DTC) is rare in children and adolescents, accounting for ~1.4% of pediatric malignancies, but its incidence is rising.
- Limited evidence exists for optimal treatment due to rarity and long patient survival, leading to numerous controversies in pediatric DTC management.
Approach:
- This review provides an overview of challenging areas in patient and disease management for pediatric papillary thyroid cancer (PTC).
- It discusses current data on diagnosis, surgical approaches, radionuclide therapy, and endocrine management.
Key Points:
- Key areas of controversy in pediatric PTC include diagnostic strategies, surgical extent, and the roles of radioactive iodine and long-term hormone suppression.
- Addressing these controversies is crucial for optimizing outcomes in this rare pediatric malignancy.
Conclusions:
- Optimal management strategies for pediatric PTC remain debated, necessitating further research and evidence-based guidelines.
- This review highlights critical areas requiring attention to improve the care and long-term outcomes for children and adolescents with PTC.
Abstract:
Although with a standardized incidence of 0.54 cases per 100,000 persons, differentiated thyroid cancer (DTC) is a rare disease in children and adolescents, it nonetheless concerns ~1.4% of all pediatric malignancies. Furthermore, its incidence is rising. Due to the rarity and long survival of pediatric DTC patients, in most areas of treatment little evidence exists. Treatment of pediatric DTC is therefore littered with controversies, many questions therefore remain open regarding the optimal management of pediatric papillary thyroid cancer (PTC), and many challenges remain unsolved. In the present review, we aim to provide an overview of these challenging areas of patient and disease management in pediatric PTC patients. Data on diagnosis, surgery, radionuclide, and endocrine therapy are discussed, and the controversies therein are highlighted.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Chronic Pancreatitis II: Collaborative Care
Assessment: